High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, Wadman J, Gorlick RG.
Meyers PA, et al. Among authors: gorlick rg.
J Clin Oncol. 2001 Jun 1;19(11):2812-20. doi: 10.1200/JCO.2001.19.11.2812.
J Clin Oncol. 2001.
PMID: 11387352
Clinical Trial.